Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality (Diagnostics Techniques, Therapeutics); End User (Hospitals, Diagnostic Laboratories, Others)

Report Code: TIPRE00013454 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Colorectal cancer, also known as colon cancer or rectal cancer, affects the colon and the rectum. There are several screening tests, kits, and medical devices used for the diagnosis of colorectal cancer. Primary causes of colorectal cancer are lifestyle disorders, aging, and diet. Moreover, colorectal cancer is a leading cause of cancer incidence and mortality among adults younger than 50 years in the US.

MARKET DYNAMICS

The colorectal cancer diagnostics market is driving due increasing incidence and prevalence of colorectal cancer, and technological advancements in radiology and chemotherapy. However, the high costs of diagnostic methods and lack of awareness in low income countries is expected to hamper the growth of the global colorectal cancer diagnostics market. Moreover, increasing government efforts to reduce mortality of colorectal cancer in developing economies is anticipated to drive demand the growth of the market for colorectal cancer diagnostics market.

MARKET SCOPE

The "Colorectal Cancer Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of colorectal cancer diagnostics market with detailed market segmentation by modality, and user. The colorectal cancer diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in colorectal cancer diagnostics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The colorectal cancer diagnostics market is segmented on the basis of modality, and end user. Based on modality, the market is segmented into diagnostics techniques, and therapeutics. Diagnostics Techniques is further sub segmented into stool tests, immunohistochemistry, colonoscopy, flexible sigmoidoscopy, and other diagnostics techniques. Therapeutics is further sub segmented into chemotherapy, immunotherapy, and others. Based on end user, the market is segmented into hospitals, diagnostic laboratories, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the colorectal cancer diagnostics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The colorectal cancer diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting colorectal cancer diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the colorectal cancer diagnostics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the colorectal cancer diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Colorectal Cancer Diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for colorectal cancer diagnostics market in the global market. Below mentioned is the list of few companies engaged in the colorectal cancer diagnostics market.

The report also includes the profiles of key players in colorectal cancer diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Amgen Inc.
  •   Clinical Genomics
  •   EDP Biotech
  •   Epigenomics AG
  •   F. Hoffmann-La Roche AG
  •   Quest Diagnostics
  •   Novigenix SA
  •   Siemens Healthineers
  •   VolitionRX

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Colorectal Cancer Diagnostics Market - By Modality
1.3.2 Colorectal Cancer Diagnostics Market - By End User
1.3.3 Colorectal Cancer Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COLORECTAL CANCER DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COLORECTAL CANCER DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COLORECTAL CANCER DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. COLORECTAL CANCER DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. COLORECTAL CANCER DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. COLORECTAL CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - MODALITY
7.1. OVERVIEW
7.2. MODALITY MARKET FORECASTS AND ANALYSIS
7.3. DIAGNOSTICS TECHNIQUES
7.3.1. Overview
7.3.2. Diagnostics Techniques Market Forecast and Analysis
7.3.3. Stool Tests Market
7.3.3.1. Overview
7.3.3.2. Stool Tests Market Forecast and Analysis
7.3.4. Immunohistochemistry Colonoscopy Market
7.3.4.1. Overview
7.3.4.2. Immunohistochemistry Colonoscopy Market Forecast and Analysis
7.3.5. Flexible Sigmoidoscopy Market
7.3.5.1. Overview
7.3.5.2. Flexible Sigmoidoscopy Market Forecast and Analysis
7.3.6. Other Diagnostics Techniques Market
7.3.6.1. Overview
7.3.6.2. Other Diagnostics Techniques Market Forecast and Analysis
7.4. THERAPEUTICS
7.4.1. Overview
7.4.2. Therapeutics Market Forecast and Analysis
7.4.3. Chemotherapy Market
7.4.3.1. Overview
7.4.3.2. Chemotherapy Market Forecast and Analysis
7.4.4. Immunotherapy Market
7.4.4.1. Overview
7.4.4.2. Immunotherapy Market Forecast and Analysis
7.4.5. Others Market
7.4.5.1. Overview
7.4.5.2. Others Market Forecast and Analysis
8. COLORECTAL CANCER DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. DIAGNOSTIC LABORATORIES
8.4.1. Overview
8.4.2. Diagnostic Laboratories Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. COLORECTAL CANCER DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Colorectal Cancer Diagnostics Market Overview
9.1.2 North America Colorectal Cancer Diagnostics Market Forecasts and Analysis
9.1.3 North America Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Modality
9.1.4 North America Colorectal Cancer Diagnostics Market Forecasts and Analysis - By End User
9.1.5 North America Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Colorectal Cancer Diagnostics Market
9.1.5.1.1 United States Colorectal Cancer Diagnostics Market by Modality
9.1.5.1.2 United States Colorectal Cancer Diagnostics Market by End User
9.1.5.2 Canada Colorectal Cancer Diagnostics Market
9.1.5.2.1 Canada Colorectal Cancer Diagnostics Market by Modality
9.1.5.2.2 Canada Colorectal Cancer Diagnostics Market by End User
9.1.5.3 Mexico Colorectal Cancer Diagnostics Market
9.1.5.3.1 Mexico Colorectal Cancer Diagnostics Market by Modality
9.1.5.3.2 Mexico Colorectal Cancer Diagnostics Market by End User
9.2. EUROPE
9.2.1 Europe Colorectal Cancer Diagnostics Market Overview
9.2.2 Europe Colorectal Cancer Diagnostics Market Forecasts and Analysis
9.2.3 Europe Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Modality
9.2.4 Europe Colorectal Cancer Diagnostics Market Forecasts and Analysis - By End User
9.2.5 Europe Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Colorectal Cancer Diagnostics Market
9.2.5.1.1 Germany Colorectal Cancer Diagnostics Market by Modality
9.2.5.1.2 Germany Colorectal Cancer Diagnostics Market by End User
9.2.5.2 France Colorectal Cancer Diagnostics Market
9.2.5.2.1 France Colorectal Cancer Diagnostics Market by Modality
9.2.5.2.2 France Colorectal Cancer Diagnostics Market by End User
9.2.5.3 Italy Colorectal Cancer Diagnostics Market
9.2.5.3.1 Italy Colorectal Cancer Diagnostics Market by Modality
9.2.5.3.2 Italy Colorectal Cancer Diagnostics Market by End User
9.2.5.4 Spain Colorectal Cancer Diagnostics Market
9.2.5.4.1 Spain Colorectal Cancer Diagnostics Market by Modality
9.2.5.4.2 Spain Colorectal Cancer Diagnostics Market by End User
9.2.5.5 United Kingdom Colorectal Cancer Diagnostics Market
9.2.5.5.1 United Kingdom Colorectal Cancer Diagnostics Market by Modality
9.2.5.5.2 United Kingdom Colorectal Cancer Diagnostics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Colorectal Cancer Diagnostics Market Overview
9.3.2 Asia-Pacific Colorectal Cancer Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Modality
9.3.4 Asia-Pacific Colorectal Cancer Diagnostics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Colorectal Cancer Diagnostics Market
9.3.5.1.1 Australia Colorectal Cancer Diagnostics Market by Modality
9.3.5.1.2 Australia Colorectal Cancer Diagnostics Market by End User
9.3.5.2 China Colorectal Cancer Diagnostics Market
9.3.5.2.1 China Colorectal Cancer Diagnostics Market by Modality
9.3.5.2.2 China Colorectal Cancer Diagnostics Market by End User
9.3.5.3 India Colorectal Cancer Diagnostics Market
9.3.5.3.1 India Colorectal Cancer Diagnostics Market by Modality
9.3.5.3.2 India Colorectal Cancer Diagnostics Market by End User
9.3.5.4 Japan Colorectal Cancer Diagnostics Market
9.3.5.4.1 Japan Colorectal Cancer Diagnostics Market by Modality
9.3.5.4.2 Japan Colorectal Cancer Diagnostics Market by End User
9.3.5.5 South Korea Colorectal Cancer Diagnostics Market
9.3.5.5.1 South Korea Colorectal Cancer Diagnostics Market by Modality
9.3.5.5.2 South Korea Colorectal Cancer Diagnostics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Colorectal Cancer Diagnostics Market Overview
9.4.2 Middle East and Africa Colorectal Cancer Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Modality
9.4.4 Middle East and Africa Colorectal Cancer Diagnostics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Colorectal Cancer Diagnostics Market
9.4.5.1.1 South Africa Colorectal Cancer Diagnostics Market by Modality
9.4.5.1.2 South Africa Colorectal Cancer Diagnostics Market by End User
9.4.5.2 Saudi Arabia Colorectal Cancer Diagnostics Market
9.4.5.2.1 Saudi Arabia Colorectal Cancer Diagnostics Market by Modality
9.4.5.2.2 Saudi Arabia Colorectal Cancer Diagnostics Market by End User
9.4.5.3 U.A.E Colorectal Cancer Diagnostics Market
9.4.5.3.1 U.A.E Colorectal Cancer Diagnostics Market by Modality
9.4.5.3.2 U.A.E Colorectal Cancer Diagnostics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Colorectal Cancer Diagnostics Market Overview
9.5.2 South and Central America Colorectal Cancer Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Modality
9.5.4 South and Central America Colorectal Cancer Diagnostics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Colorectal Cancer Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Colorectal Cancer Diagnostics Market
9.5.5.1.1 Brazil Colorectal Cancer Diagnostics Market by Modality
9.5.5.1.2 Brazil Colorectal Cancer Diagnostics Market by End User
9.5.5.2 Argentina Colorectal Cancer Diagnostics Market
9.5.5.2.1 Argentina Colorectal Cancer Diagnostics Market by Modality
9.5.5.2.2 Argentina Colorectal Cancer Diagnostics Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL COLORECTAL CANCER DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. COLORECTAL CANCER DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AMGEN INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CLINICAL GENOMICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EDP BIOTECH
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. EPIGENOMICS AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. QUEST DIAGNOSTICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVIGENIX SA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SIEMENS HEALTHINEERS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VOLITIONRX
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Amgen Inc.
3. Clinical Genomics
4. EDP Biotech
5. Epigenomics AG
6. F. Hoffmann-La Roche AG
7. Quest Diagnostics
8. Novigenix SA
9. Siemens Healthineers
10. VolitionRX
TIPRE00013454
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking